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undergoing hematopoietic stem cell transplantation (HSCT),
low socioeconomic status (SES) is associated with worse
outcomes and higher mortality. Assessment of SES in these
studies has generally been limited to a single dimension such
as household income. We examined outcome after HSCT as a
function of ﬁnancial resources at the household and com-
munity level, and explored whether their association with
survival reﬂected educational disparities.
Method: 383 patients underwent allogeneic HSCT (57%
male; 82% White; mean age 50 y; 66% leukemia, 21% lym-
phoma). Pre-transplant, a social worker documented pa-
tients’ ﬁnancial resources and educational background. Via
census data, we derivedmedian household income and high-
school graduation rates at the census-block level. HSCT
outcomes over six years were obtained frommedical records.
Results: Controlling for demographics (age, gender, race,
marital status) and medical factors (disease, pre-transplant
chemotherapy, remission status, cell dose, donor-recipient
CMV status, donor sex), greater pre-transplant ﬁnancial re-
sources were associated with longer survival (HR 1.55;
p¼0.007), as was higher median neighborhood income (HR
1.52; p¼0.02). When entered simultaneously, higher ﬁnan-
cial resources (HR 1.45; p¼0.03) and neighborhood income
(HR 1.54, p¼0.06) continued to predict longer survival.
Adding educational attainment did not change the magni-
tude of these associations (ﬁnancial resources HR 1.60;
neighborhood income HR 1.90). Also, greater pre-transplant
ﬁnancial resources were associated with lower non-relapse
mortality (NRM) than lower resources (HR 0.45; p¼0.03).
Conclusions: Greater ﬁnancial resources are associated with
lower non-relapse mortality and higher 2-year overall sur-
vival post-HSCT. This association is independent of educa-
tional attainment, suggesting that it reﬂects the inﬂuence of
resources as opposed to knowledge or health literacy.221
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Infertility is one of the late effects in patients receiving he-
matopoietic stem cell transplantation (HSCT).The aim of this
study was to assess fertility in survivors following HSCT.
The study included 2698 HSCT survivors (aged>18) who
underwent transplantation between July 3, 1990 and August
30, 2014. The inclusion criterion for women entered the
study was the age of less than 50 years at the time of
transplantation. HSCT recipients (females and males) aged
over18 were determined eligible to participate in the study.
The study group consisted of 1714(63.5%) males and
984(36.5%) females withmean age of 31.5 years (range: 2-78)
at the time of HSCT. Median follow-up was 44 months
(1-286).
In this study, pregnancies occurred in female HSCT re-
cipients and in female partners of male recipients. There were
86 pregnancies (19 females and 67 males) following sponta-
neous conception (n¼54) and in vitro fertilization (ivF) treat-
ment with either their own eggs or donated eggs. The median
age of pregnancy in our participants was 31 years. Autologous
(n¼34), allogeneic (n¼50), and syngeneic (n¼2) hematopoi-
etic stem cells were primarily used in this study. AML (30%)
and HD (16.3%) were common diseases among pregnantwomen. The interval time between HST and fertility was 63
months.
Conclusion: The results of the survey showed that some
recipients are able to preserve their fertility following HSCT.
In order to increase the rate of pregnancies in HSCT survivors,
they should be informed about the impact of late effects of
HSCT on their fertility prior to treatment entry.
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Introduction: Patients diagnosed with cancer may experi-
ence psychological issues that can interfere with treatment
plans and adversely affect outcomes. Patients should be
screened for distress during pivotal medical visits. The
St. Louis University Blood and Marrow Transplant Program
(SLUBMT) began implementing the State Trait Anxiety In-
ventory (STAI) with patients duringmedical visits to evaluate
feelings of anxiety. Under normal conditions, average STAI
scores are: 35.72 (state)/34.89 (trait) for working, male
adults and 35.20 (state)/34.79 (trait) for working, female
adults. After implementing the STAI, it was realized that
these screenings could be analyzed in groups to determine if
patterns emerged regarding patients’ anxiety throughout the
bone marrow transplantation (BMT) process. The STAI has
been utilized in studies to determine the effectiveness of
interventions to decrease anxiety; however the study team is
unable to ﬁnd longitudinal studies which examine how STAI
scores are naturally affected over the course of the BMT
process.
Method: Institutional Review Board approval was received
to perform a retrospective examination of STAIs completed
by patients throughout the BMT process at the SLUBMT from
03/11/14 through 06/24/14. 30 inventories were collected,
de-identiﬁed, and categorized by the following medical
visits: arrival visit (ﬁrst visit to the clinic), data review visit
(visit to review transplant related testing and sign consents),
start of preparative regimen visit, day 0 visit, day +30 bone
marrow biopsy visit for allogenic transplantation, day +30
bonemarrow biopsy result visit for allogenic transplantation,
and day +100 visit for auto transplantation. Averages for each
category were determined by ﬁnding the mean score. Scores
were then compared to determine which medical visit(s)
caused patients to experience an increase in anxiety.
Results: Average scores were 46 (state)/38 (trait) during the
arrival visits, 41 (state)/45 (trait) during the data review
visits, and 44 (state)/39 (trait) during the start of preparative
regimen visits. During day 0 visits, patients’ scores decreased
to an average of 36 (state)/35 (trait). Day +30 and day +100
visits demonstrated even further decreases in anxiety scores.
Conclusion: Patients experience the highest levels of anxiety
during early medical visits of the BMT process. The sample
size was small and could possibly skew results. However, this
study does provide a starting basis for future study in BMT
recipient distress, andmulti-site studies are being planned to
ensure the accuracy of the patterns, which emerged from
this study. If patterns could be accurately predicted, the
study team may also be able to develop future studies to
preemptively lower patients’ anxiety levels early in the BMT
process and thus improve outcomes.
